Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.it.2020.03.007 http://scihub22266oqcxt.onion/10.1016/j.it.2020.03.007 32249063!7129017!32249063     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Trends+Immunol 2020 ; 41 (5): 355-359 Nephropedia Template TP {{tp|p=32249063|t=2020. Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses |pdf=|usr=}}{{32249063}} gab.com Text Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses JO: Trends Immunol http://www.kidney.de/pget.php?&tw=1&pmid=32249063 #FOAvip Coronavirus (CoV) disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS)-CoV-2 (also known as 2019-nCoV) is threatening global public health, social stability, and economic development. To meet this challenge, this article discusses advances in the research and development of neutralizing antibodies (nAbs) for the prevention and treatment of infection by SARS-CoV-2 and other human CoVs. Twit Text FOAVip Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses ????Trends Immunol http://www.kidney.de/pget.php?&tw=1&pmid=32249063 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32249063 #FOAvip English Wikipedia <ref>{{Cite pmid|32249063}}</ref> Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses #MMPMID32249063 Jiang S; Hillyer C; Du L Trends Immunol 2020[May]; 41 (5): 355-359 PMID32249063show ga Coronavirus (CoV) disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS)-CoV-2 (also known as 2019-nCoV) is threatening global public health, social stability, and economic development. To meet this challenge, this article discusses advances in the research and development of neutralizing antibodies (nAbs) for the prevention and treatment of infection by SARS-CoV-2 and other human CoVs. |Antibodies, Neutralizing/immunology/*therapeutic use[MESH] |Antibodies, Viral/immunology/*therapeutic use[MESH] |Betacoronavirus/*immunology[MESH] |COVID-19[MESH] |Coronavirus Infections/*immunology/prevention & control/therapy[MESH] |Coronavirus/*immunology[MESH] |Humans[MESH] |Pandemics/prevention & control[MESH] |Pneumonia, Viral/*immunology/prevention & control/therapy[MESH] |Research/trends[MESH]Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronavirus(epmc).pdf DeepDyve Pubget Overpricing